New troglitazone derivatives devoid of PPAR agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines

By Colin Christelle   Salamone Stéphane   Grillier-Vuissoz Isabelle   Boisbrun Michel   Kuntz Sandra   Lecomte Julie   Chapleur Yves   Flament Stéphane  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 101-110

Springer Publishing Company

Access to resources Recommend Favorite

Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors

By Zapata J.M.   Krajewska M.   Krajewski S.   Huang R-P.   Takayama S.   Wang H-G.   Adamson E.   Reed a.J.C.  

Breast Cancer Research and Treatment, Vol. 47, Iss. 2, 1998-01 ,pp. : 129-140

Springer Publishing Company

Access to resources Recommend Favorite

Hormone Sensitivity is Reflected in the Phospholipid Profiles of Breast Cancer Cell Lines

By Sterin Marina   Cohen Jack S.   Ringel Israel  

Breast Cancer Research and Treatment, Vol. 87, Iss. 1, 2004-09 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Steroid hormone receptors in breast cancer management

By Osborne C.K.  

Breast Cancer Research and Treatment, Vol. 51, Iss. 3, 1998-10 ,pp. : 227-238

Springer Publishing Company

Access to resources Recommend Favorite

EGFR and EGFRvIII Expression in Primary Breast Cancer and Cell Lines

By Rae James M.   Scheys Joshua O.  

Breast Cancer Research and Treatment, Vol. 87, Iss. 1, 2004-09 ,pp. : 87-95

Springer Publishing Company

Access to resources Recommend Favorite